Does MORNIFLUMATE Cause Benign prostatic hyperplasia? 72 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Benign prostatic hyperplasia have been filed in association with MORNIFLUMATE. This represents 18.4% of all adverse event reports for MORNIFLUMATE.
72
Reports of Benign prostatic hyperplasia with MORNIFLUMATE
18.4%
of all MORNIFLUMATE reports
1
Deaths
72
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From MORNIFLUMATE?
Of the 72 reports, 1 (1.4%) resulted in death, 72 (100.0%) required hospitalization, and 7 (9.7%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MORNIFLUMATE. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does MORNIFLUMATE Cause?
Dyspnoea (242)
Asthma (234)
Obstructive airways disorder (229)
Wheezing (229)
Therapeutic product effect incomplete (227)
Full blood count abnormal (216)
Loss of personal independence in daily activities (201)
Productive cough (159)
Vasculitis (145)
Condition aggravated (144)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which MORNIFLUMATE Alternatives Have Lower Benign prostatic hyperplasia Risk?
MORNIFLUMATE vs MORPHINE
MORNIFLUMATE vs MORPHINE\NALTREXONE
MORNIFLUMATE vs MOSAPRIDE
MORNIFLUMATE vs MOSUNETUZUMAB
MORNIFLUMATE vs MOSUNETUZUMAB-AXGB